Liss' Lowdown
Liss' Lowdown Ep2
Preclinical Breakthrough of the week:
Drug candidate for Fatty Liver Disease shows promise in preclinical studies at the 密西根大学 ????
A recently developed glycine-based tripeptide (DT-109) was designed by researchers at the University of Michigan to treat the severe form of fatty liver disease called nonalcoholic steatohepatitis (NASH). The disease causes scarring and inflammation in the liver and is estimated to affect up to 6.5% of the global population.
Results reveal that DT-109 reversed fat build-up and prevented scarring in the livers of both mice and primates that had developed NASH. Which is particularly promising as scientists have been trying to develop a treatment NASH for years, but many attempts have failed to show an improvement. Next stop - Clinical trials!
Clinical Breakthrough of the week:
BeVinced launches MedTech CRO services ???
领英推荐
BeVinced, a new leading CRO, set up by Joris Bannenberg MD PhD and Dirk Meijer MD MSc PhD specialises in Medical Device Regulation (MDR) compliance services.
The company is aimed at addressing the unique needs of the medical device industry. Services include, but are not limited to, clinical trial design and management, regulatory strategy and submissions, post-market surveillance, vigilance, CER-writing and technical documentation support as well as Legal Representative services.
Partnership of the week:
Limerston Capital has acquired Concept Life Sciences ??????????????
Since 2020, the UK-based CRO, Concept Life Sciences has made considerable investments in expanding its capacities. They have built top-notch biology facilities in Oncology and Immunology, offering unrivalled insights into quickly expanding speciality therapeutic fields and fostering innovation. Around 300 renowned scientists and more than 100 PhDs now make up its staff.?
The organisation will be able to use the additional commercial and technical flexibility coming from Limerston Captial's backing, to establish and expand its services to a new and existing customer base thanks to a new growth plan under the direction of new chief executive Ben Cliff .